Glück Conviction Score™ ⓘ
AKTS
Aktis Oncology, Inc.
ⓘ
Eingeschränkte Aussagekraft — erst 50 % der Signal-Gewichte sind mit Daten unterlegt.
🟢
Conviction × Timing — fundamental hohe Conviction trifft auf ein positiv drehendes Timing (Momentum/FTD). Der günstige Quadrant des Modells.
Effektiv: Sehr stark
Niedrig
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
74,4
65 neu, 0 erhöht, 549,7M $ netto
Aktivist
96,7
13D-Filing vorhanden
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 19.24 | +14.0 % vs SMA50 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 19.64 | EMA50: 19.43 | |
| MACD-Histogramm | Bullisch | 10 % | 0.073 | Bullisch | |
| RSI(14) | Neutral | 10 % | 62.8 | Neutral (30–70) | |
| Stoch %K(14) | Bärisch | 5 % | 84.6 | Überkauft | |
| ADX(14)+DI | Neutral | 10 % | 13.6 | +DI: 23.4 / −DI: 15.6 | |
| Z-Score(60) | Bärisch | 5 % | 2.11 | Extrem überkauft | |
| 52W-Position | Bullisch | 5 % | 93.5 % | Hoch 22.40 / Tief 15.19 | |
| Bollinger(20,2σ) | Bärisch | 5 % | 117.0 % | Upper 21.35 / Mid 19.63 / Lower 17.91 | |
| LinReg-Slope(60) | Neutral | 10 % | +0.0446 | R²=0.30 / annualisiert +59.2 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-01-12 | Vida Ventures II, LLC | 10% Owner | Open Market Purchase | 22.545 | 18,00 | 405.810,00 | +3,2% | |
| 2026-01-12 | Vida Ventures II, LLC | 10% Owner | Open Market Purchase | 812.455 | 18,00 | 14.624.190,00 | +115,1% | |
| 2026-01-12 | EcoR1 Capital, LLC | Director | Open Market Purchase | 144.443 | 18,00 | 2.599.974,00 | +20,5% | |
| 2026-01-12 | EcoR1 Capital, LLC | Director | Open Market Purchase | 2.077.779 | 18,00 | 37.400.022,00 | +294,5% | |
| 2026-01-12 | Kim Helen Susan | Director, 10% Owner | Open Market Purchase | 22.545 | 18,00 | 405.810,00 | +3,2% | |
| 2026-01-12 | Kim Helen Susan | Director, 10% Owner | Open Market Purchase | 812.455 | 18,00 | 14.624.190,00 | +115,1% | |
| 2026-01-12 | Foley Todd | Director, 10% Owner | Open Market Purchase | 232.870 | 18,00 | 4.191.660,00 | +33,0% | |
| 2026-01-12 | MPM BIOVENTURES 2018, L.P. | 10% Owner | Open Market Purchase | 1.112.777 | 18,00 | 20.029.986,00 | +157,7% | |
| 2026-01-12 | GADICKE ANSBERT | 10% Owner | Open Market Purchase | 1.112.777 | 18,00 | 20.029.986,00 | +157,7% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| MPM BioImpact LLC | 4.835.872 | 0 | 4.835.872 | 86.513.750 | Neu | +100,0% | |
| EcoR1 Capital, LLC | 4.824.469 | 0 | 4.824.469 | 86.309.750 | Neu | +100,0% | |
| Blue Owl Capital Holdings LP | 3.161.348 | 0 | 3.161.348 | 56.556.516 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 2.317.044 | 0 | 2.317.044 | 41.451.917 | Neu | +100,0% | |
| BlackRock, Inc. | 2.112.127 | 0 | 2.112.127 | 37.785.952 | Neu | +100,0% | |
| RTW INVESTMENTS, LP | 1.592.043 | 0 | 1.592.043 | 28.481.649 | Neu | +100,0% | |
| RA CAPITAL MANAGEMENT, L.P. | 1.503.084 | 0 | 1.503.084 | 26.890.173 | Neu | +100,0% | |
| JANUS HENDERSON GROUP PLC | 1.454.267 | 0 | 1.454.267 | 26.022.437 | Neu | +100,0% | |
| BAKER BROS. ADVISORS LP | 996.351 | 0 | 996.351 | 17.824.719 | Neu | +100,0% | |
| Octagon Capital Advisors LP | 960.847 | 0 | 960.847 | 17.189.553 | Neu | +100,0% | |
| Merck & Co., Inc. | 952.844 | 0 | 952.844 | 17.046.379 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 833.913 | 0 | 833.913 | 14.918.704 | Neu | +100,0% | |
| EVENTIDE ASSET MANAGEMENT, LLC | 507.000 | 0 | 507.000 | 9.070.230 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 491.936 | 0 | 491.936 | 8.803.406 | Neu | +100,0% | |
| Avidity Partners Management LP | 468.566 | 0 | 468.566 | 8.382.646 | Neu | +100,0% | |
| STATE STREET CORP | 428.253 | 0 | 428.253 | 7.661.446 | Neu | +100,0% | |
| a16z Capital Management, L.L.C. | 415.000 | 0 | 415.000 | 7.424.350 | Neu | +100,0% | |
| FMR LLC | 386.379 | 0 | 386.379 | 6.912.320 | Neu | +100,0% | |
| UBS Group AG | 353.263 | 0 | 353.263 | 6.319.875 | Neu | +100,0% | |
| ArrowMark Colorado Holdings LLC | 329.471 | 0 | 329.471 | 5.894.236 | Neu | +100,0% | |
| Alyeska Investment Group, L.P. | 290.000 | 0 | 290.000 | 5.188.100 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 162.017 | 0 | 162.017 | 2.898.484 | Neu | +100,0% | |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 150.000 | 0 | 150.000 | 2.683.500 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 149.476 | 0 | 149.476 | 2.674.125 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 102.925 | 0 | 102.925 | 1.841.329 | Neu | +100,0% | |
| TD ASSET MANAGEMENT INC | 100.962 | 0 | 100.962 | 1.806.210 | Neu | +100,0% | |
| SOROS FUND MANAGEMENT LLC | 100.000 | 0 | 100.000 | 1.789.000 | Neu | +100,0% | |
| Laurion Capital Management LP | 100.000 | 0 | 100.000 | 1.789.000 | Neu | +100,0% | |
| Woodline Partners LP | 100.000 | 0 | 100.000 | 1.789.000 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 75.000 | 0 | 75.000 | 1.341.750 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 69.926 | 0 | 69.926 | 1.250.976 | Neu | +100,0% | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 46.993 | 0 | 46.993 | 840.705 | Neu | +100,0% | |
| MORGAN STANLEY | 30.723 | 0 | 30.723 | 549.634 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 30.163 | 0 | 30.163 | 539.616 | Neu | +100,0% | |
| READYSTATE ASSET MANAGEMENT LP | 30.000 | 0 | 30.000 | 536.700 | Neu | +100,0% | |
| SEVEN GRAND MANAGERS, LLC | 25.000 | 0 | 25.000 | 447.250 | Neu | +100,0% | |
| Ghisallo Capital Management LLC | 25.000 | 0 | 25.000 | 447.250 | Neu | +100,0% | |
| Nuveen, LLC | 24.468 | 0 | 24.468 | 437.733 | Neu | +100,0% | |
| RHUMBLINE ADVISERS | 21.033 | 0 | 21.033 | 376.274 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 17.062 | 0 | 17.062 | 305.239 | Neu | +100,0% | |
| Zimmer Partners, LP | 15.000 | 0 | 15.000 | 268.350 | Neu | +100,0% | |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 14.185 | 0 | 14.185 | 253.770 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 14.080 | 0 | 14.080 | 251.891 | Neu | +100,0% | |
| XTX Topco Ltd | 13.990 | 0 | 13.990 | 250.281 | Neu | +100,0% | |
| Invesco Ltd. | 12.113 | 0 | 12.113 | 216.701 | Neu | +100,0% | |
| MetLife Investment Management, LLC | 11.637 | 0 | 11.637 | 208.186 | Neu | +100,0% | |
| BARCLAYS PLC | 9.724 | 0 | 9.724 | 173.963 | Neu | +100,0% | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 9.651 | 0 | 9.651 | 172.656 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 7.611 | 0 | 7.611 | 136.161 | Neu | +100,0% | |
| PNC FINANCIAL SERVICES GROUP, INC. | 6.948 | 0 | 6.948 | 124.300 | Neu | +100,0% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| MPM BioImpact LLC | 4.835.872 | 0 | +100,0% | 86.513.750 | 15,74 |
| EcoR1 Capital, LLC | 4.824.469 | 0 | +100,0% | 86.309.750 | 15,70 |
| Blue Owl Capital Holdings LP | 3.161.348 | 0 | +100,0% | 56.556.516 | 10,29 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.317.044 | 0 | +100,0% | 41.451.917 | 7,54 |
| BlackRock, Inc. | 2.112.127 | 0 | +100,0% | 37.785.952 | 6,87 |
| RTW INVESTMENTS, LP | 1.592.043 | 0 | +100,0% | 28.481.649 | 5,18 |
| RA CAPITAL MANAGEMENT, L.P. | 1.503.084 | 0 | +100,0% | 26.890.173 | 4,89 |
| JANUS HENDERSON GROUP PLC | 1.454.267 | 0 | +100,0% | 26.022.437 | 4,73 |
| BAKER BROS. ADVISORS LP | 996.351 | 0 | +100,0% | 17.824.719 | 3,24 |
| Octagon Capital Advisors LP | 960.847 | 0 | +100,0% | 17.189.553 | 3,13 |
| Merck & Co., Inc. | 952.844 | 0 | +100,0% | 17.046.379 | 3,10 |
| VANGUARD CAPITAL MANAGEMENT LLC | 833.913 | 0 | +100,0% | 14.918.704 | 2,71 |
| EVENTIDE ASSET MANAGEMENT, LLC | 507.000 | 0 | +100,0% | 9.070.230 | 1,65 |
| GEODE CAPITAL MANAGEMENT, LLC | 491.936 | 0 | +100,0% | 8.803.406 | 1,60 |
| Avidity Partners Management LP | 468.566 | 0 | +100,0% | 8.382.646 | 1,52 |
| STATE STREET CORP | 428.253 | 0 | +100,0% | 7.661.446 | 1,39 |
| a16z Capital Management, L.L.C. | 415.000 | 0 | +100,0% | 7.424.350 | 1,35 |
| FMR LLC | 386.379 | 0 | +100,0% | 6.912.320 | 1,26 |
| UBS Group AG | 353.263 | 0 | +100,0% | 6.319.875 | 1,15 |
| ArrowMark Colorado Holdings LLC | 329.471 | 0 | +100,0% | 5.894.236 | 1,07 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 69 | 37,6 | 606 |
| 31.12.2025 | ✓ | 3 | 0,0 | 0 |
| 30.09.2025 | ✓ | 1 | 0,0 | 0 |
| 31.03.2025 | ✓ | 2 | 0,0 | 0 |
| 31.12.2024 | ✓ | 12 | 0,6 | 0 |
| 30.09.2024 | vorl. | 74 | 21,2 | 2 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| Kohmann Bosshard Financial Services, LLC | 27.756 | 0 |
| VSM Wealth Advisory, LLC | 50 | 0 |
Top 10 Aufstocker
Keine Aufstocker.Top 10 Verkäufer
Keine Verkaeufer.Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 14.05.2026 | Blue Owl Capital Holdings LP | Passiv (13G) | 5,92 % | 3.161.348 | Neu | |
| 20.01.2026 | ANSBERT GADICKE | Aktivist (13D) | 19,30 % | 10.260.064 | Neu | The MPM Entities acquired the securities reported herein for investment purposes and not… |
| 20.01.2026 | LUKE EVNIN | Aktivist (13D) | 9,50 % | 5.082.483 | Neu | The MPM Entities acquired the securities reported herein for investment purposes and not… |
| 20.01.2026 | MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Aktivist (13D) | 0,10 % | 77.911 | Neu | The MPM Entities acquired the securities reported herein for investment purposes and not… |
| 20.01.2026 | MPM ASSET MANAGEMENT LLC | Aktivist (13D) | 0,60 % | 341.709 | Neu | The MPM Entities acquired the securities reported herein for investment purposes and not… |
| 20.01.2026 | MPM BIOVENTURES 2018 (B), L.P. | Aktivist (13D) | 0,40 % | 206.964 | Neu | The MPM Entities acquired the securities reported herein for investment purposes and not… |
| 20.01.2026 | MPM BioVentures 2018 GP LLC | Aktivist (13D) | 7,80 % | 4.157.492 | Neu | The MPM Entities acquired the securities reported herein for investment purposes and not… |
| 20.01.2026 | MPM BioVentures 2018 LLC | Aktivist (13D) | 7,90 % | 4.235.403 | Neu | The MPM Entities acquired the securities reported herein for investment purposes and not… |
| 20.01.2026 | MPM BIOVENTURES 2018, L.P. | Aktivist (13D) | 7,40 % | 3.950.528 | Neu | The MPM Entities acquired the securities reported herein for investment purposes and not… |
| 20.01.2026 | MPM Oncology Innovations Fund GP LLC | Aktivist (13D) | 1,60 % | 847.080 | Neu | The MPM Entities acquired the securities reported herein for investment purposes and not… |
| 20.01.2026 | MPM ONCOLOGY INNOVATIONS FUND LP | Aktivist (13D) | 1,60 % | 847.080 | Neu | The MPM Entities acquired the securities reported herein for investment purposes and not… |
| 20.01.2026 | MPM Oncology Investments 2 LLC | Aktivist (13D) | 9,10 % | 4.835.872 | Neu | The MPM Entities acquired the securities reported herein for investment purposes and not… |
| 20.01.2026 | Oncology Impact Private Investment Fund 2, L.P. | Aktivist (13D) | 9,10 % | 4.835.872 | Neu | The MPM Entities acquired the securities reported herein for investment purposes and not… |
| 20.01.2026 | Todd Foley | Aktivist (13D) | 8,00 % | 4.237.506 | Neu | The MPM Entities acquired the securities reported herein for investment purposes and not… |
| 20.01.2026 | Oleg Nodelman | Aktivist (13D) | 9,10 % | 4.862.335 | Neu | Oleg Nodelman, the manager of EcoR1, is a member of the Issuer's board of directors. Th… |
| 20.01.2026 | EcoR1 Capital, LLC | Aktivist (13D) | 9,10 % | 4.824.469 | Neu | Oleg Nodelman, the manager of EcoR1, is a member of the Issuer's board of directors. Th… |
| 20.01.2026 | EcoR1 Capital Fund Qualified, L.P. | Aktivist (13D) | 8,20 % | 4.348.658 | Neu | Oleg Nodelman, the manager of EcoR1, is a member of the Issuer's board of directors. Th… |
| 15.01.2026 | Eli Lilly and Company | Aktivist (13D) | 11,90 % | 6.344.114 | Neu | The Reporting Person acquired the securities reported herein for investment purposes and… |
| 14.01.2026 | Vida Ventures II-A, LLC | Aktivist (13D) | 0,30 % | 157.387 | Neu | The information set forth in Item 3 of this Statement is incorporated herein by referenc… |
| 14.01.2026 | VV Manager II LLC | Aktivist (13D) | 10,90 % | 5.829.212 | Neu | The information set forth in Item 3 of this Statement is incorporated herein by referenc… |
| 14.01.2026 | Helen Kim | Aktivist (13D) | 10,90 % | 5.831.315 | Neu | The information set forth in Item 3 of this Statement is incorporated herein by referenc… |
| 14.01.2026 | Vida Ventures II, LLC | Aktivist (13D) | 10,60 % | 5.671.825 | Neu | The information set forth in Item 3 of this Statement is incorporated herein by referenc… |
| 12.11.2024 | The Vanguard Group | Passiv (13G/A) | 2,24 % | 3.225.431 | 0,00 pp | |
| 04.11.2024 | The Vanguard Group | Passiv (13G) | 2,24 % | 3.225.431 | -2,76 pp | |
| 13.02.2024 | The Vanguard Group | Passiv (13G) | 5,00 % | 3.626.804 | Neu | |
| 09.02.2024 | Senvest Management, LLC | Passiv (13G/A) | 3,00 % | 2.196.577 | -2,30 pp | |
| 09.02.2024 | Richard Mashaal | Passiv (13G/A) | 3,00 % | 2.196.577 | -2,30 pp | |
| 07.02.2024 | . BlackRock, Inc. | Passiv (13G/A) | 4,90 % | 4.847.887 | -2,00 pp | |
| 26.01.2024 | . BlackRock, Inc. | Passiv (13G) | 6,90 % | 5.012.476 | +2,30 pp | |
| 14.09.2023 | Richard Mashaal | Passiv (13G) | 5,30 % | 3.802.592 | Neu | |
| 14.09.2023 | Senvest Management, LLC | Passiv (13G) | 5,30 % | 3.802.592 | Neu | |
| 08.03.2023 | . BlackRock, Inc. | Passiv (13G/A) | 4,60 % | 3.313.517 | -0,10 pp | |
| 09.02.2023 | . BlackRock, Inc. | Passiv (13G/A) | 4,70 % | 3.342.384 | -1,00 pp | |
| 01.02.2023 | . BlackRock, Inc. | Passiv (13G/A) | 5,70 % | 3.276.405 | 0,00 pp | |
| 04.02.2022 | . BlackRock, Inc. | Passiv (13G) | 5,70 % | 2.965.937 | 0,00 pp |
Stammdaten
Aktis Oncology, Inc. ist ein klinisches Biotechnologie-Unternehmen, das sich dem Vorantreiben zielgerichteter Radiopharmaka-Therapien zur Krebsbehandlung widmet. Die Kerninnovation liegt in einer proprietären Miniprotein-Radiokonjugat-Plattform, die die Entdeckung und Entwicklung potenter Radiopharmaka-Therapien ermöglicht, die für eine präzise Abgabe tumorabbauender Radioisotope konzipiert sind. Unter den Pipeline-Kandidaten befindet sich Nectin-4, ein Miniprotein-Radiokonjugat, speziell entwickelt zur Behandlung lokal fortgeschrittener oder metastatischer Urothel-Krebs. Zu wichtigen Programmen gehört auch AKY-1189, ein Radiokonjugat, entwickelt zur Bekämpfung von Tumoren, die Nectin-4 exprimieren, in verschiedenen Indikationen wie metastatischem Urothel-Krebs, Brustkrebs, nicht-kleinzeligem Lungenkrebs (NSCLC), Darmkrebs und Gebärmutterhalskrebs. Eine weitere bedeutsame Therapie, AKY-2519, befindet sich in Entwicklung, um Radioisotope an Tumoren abzugeben, die B7-H3 (CD276) exprimieren, und adressiert Prostatakrebs, Lungenkrebs und andere Arten von Festkörpertumoren. Das Unternehmen wurde ursprünglich als HotKnot Therapeutics, Inc. gegründet und wurde offiziell im April 2020 in Aktis Oncology, Inc. umbenannt. Gegründet 2020, hat Aktis Oncology seinen Hauptsitz in Boston, Massachusetts.
Unternehmen & Branche
| Name | Aktis Oncology, Inc. |
|---|---|
| Ticker | AKTS |
| CIK | 0002035832 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 01021M104 |
|---|---|
| ISIN | US01021M1045 |
| Typ | Common Stock |
| Marktkapitalisierung | 1,13 Mrd. USD |
| Dividendenrendite | 0,00 % |
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 3.227.000 | -18.325.000 | -0,38 | 576.801.000 | 506.108.000 |
| 2025-03-31 | 10-Q | 1.447.000 | -14.985.000 | -18,60 | -101.561.000 |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 11.05.2026 | 3,2 Mio. USD | -0,38 |
| Q1 2025 | 31.03.2025 | 11.05.2026 | 1,4 Mio. USD | -18,60 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 11.05.2026 | 10-Q | 31.03.2026 | 41 Tage | SEC » |
| 30.03.2026 | 10-K | 31.12.2025 | 89 Tage | SEC » |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-14 | 2 | 19,53 | 39 |
| 2026-05-01 | 7.251 | 18,75 | 135.956 |
| 2026-04-28 | 293 | 20,09 | 5.886 |
| 2026-04-27 | 954 | 21,26 | 20.282 |
| 2026-04-24 | 506 | 22,08 | 11.172 |
| 2026-04-23 | 100 | 22,00 | 2.200 |
| 2026-04-22 | 5 | 20,50 | 103 |
| 2026-04-21 | 42 | 20,83 | 875 |
| 2026-04-20 | 90 | 20,25 | 1.823 |
| 2026-04-16 | 5 | 18,09 | 90 |
| 2026-04-15 | 399 | 17,84 | 7.118 |
| 2026-04-08 | 1.440 | 16,72 | 24.077 |
| 2026-04-07 | 1.802 | 16,37 | 29.499 |
| 2026-04-06 | 5.988 | 17,37 | 104.012 |
| 2026-04-01 | 12.331 | 17,89 | 220.602 |
| 2026-03-31 | 17.716 | 16,54 | 293.023 |
| 2026-03-30 | 11.687 | 15,19 | 177.526 |
| 2026-03-25 | 52.735 | 18,63 | 982.453 |
| 2026-03-24 | 76.605 | 18,18 | 1.392.679 |
| 2026-03-23 | 195.591 | 17,70 | 3.461.961 |
| 2026-03-06 | 51 | 20,54 | 1.048 |
| 2026-03-05 | 974 | 20,85 | 20.308 |
| 2026-03-04 | 135 | 20,22 | 2.730 |
| 2026-03-03 | 1.399 | 20,00 | 27.980 |
| 2026-02-27 | 602 | 19,63 | 11.817 |
| 2026-02-25 | 2.851 | 20,00 | 57.020 |
| 2026-02-24 | 5.761 | 19,43 | 111.936 |
| 2026-02-17 | 14.136 | 17,76 | 251.055 |
| 2026-02-13 | 2.894 | 17,90 | 51.803 |
| 2026-02-12 | 7.823 | 18,06 | 141.283 |
| 2026-02-03 | 3.675 | 21,98 | 80.777 |
| 2026-01-27 | 292 | 21,62 | 6.313 |
| 2026-01-23 | 3.890 | 22,40 | 87.136 |
| 2026-01-22 | 8.890 | 20,40 | 181.356 |
| 2026-01-16 | 1.881 | 20,56 | 38.673 |
| 2026-01-14 | 56.762 | 21,35 | 1.211.869 |
| 2026-01-13 | 19.055 | 21,75 | 414.446 |
| 2026-01-12 | 39.942 | 22,40 | 894.701 |